PSC
ABBV icon

Portman Square Capital’s AbbVie ABBV Stock Holding History

Portman Square Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,828
Closed -$341K – 308
2024
Q2 		$314K Sell
1,828
-824
-31% -$136K 0.01% 312
2024
Q1 		$483K Sell
2,652
-8,009
-75% -$1.38M 0.01% 262
2023
Q4 		$1.65M Buy
10,661
+2,939
+38% +$428K 0.04% 311
2023
Q3 		$1.15M Sell
7,722
-8,989
-54% -$1.32M 0.03% 356
2023
Q2 		$2.25M Buy
16,711
+14,456
+641% +$2.12M 0.06% 227
2023
Q1 		$359K Buy
+2,255
New +$345K 0.02% 280

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Portman Square Capital's ABBV Position: Q3 2024 in Review

Portman Square Capital sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 1,828 shares — an estimated $341K sold.

Portman Square Capital first reported a position in ABBV in Q1 2023 and held it in 6 quarters. The position peaked at $2.25M in Q2 2023. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Portman Square Capital reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
  • Portman Square Capital sold 1,828 AbbVie shares in Q3 2024, an estimated $341K.
  • Portman Square Capital first reported a position in AbbVie in Q1 2023 and held it in 6 quarters.
  • Portman Square Capital's AbbVie position peaked at $2.25M in Q2 2023.
  • 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Portman Square Capital's 13F filing for Q3 2024, filed 16 Oct 2024.